REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/13/2026
Back to search
Official data from USPTO
PHARMACEUTICAL SOCIAL ENTERPRISE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMACEUTICAL SOCIAL ENTERPRISE
ST13
US500000086944352Class
44
Filing
86944352
Registration
5224224
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/14/2026
Trademark type
Word
Nice classes
44
Filing date
03/17/2016
Registration date
06/13/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/03/2024
Last transaction
06/14/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2017
First use in commerce
03/01/2017
Drawing code
4
Owner type
03
Owner location
West Chicago, IL, US
Examiner
SOMERVILLE, ARETHA CHARESE
Law office
L70
Current location
TMEG LAW OFFICE 107
Holders and representatives
Holders
OWP Pharmaceuticals, Inc.
OWP Pharmaceuticals, Inc.
Representatives
Kenneth S. McLaughlin, Jr. LAW OFFICES OF MCLAUGHLIN & ASSOCIATES, P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Charitable servicesproviding medical services to underdeveloped countries; Health care services for treating epilepsy
Publications
History of USPTO decisions and trademark events.
32 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/03/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/03/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/11/2023
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
12/11/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2023
E815
TEAS SECTION 8 & 15 RECEIVED
06/08/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/13/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/12/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/11/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/19/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/16/2017
IUAF
USE AMENDMENT FILED
04/04/2017
EISU
TEAS STATEMENT OF USE RECEIVED
04/04/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/04/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/09/2016
PUBO
PUBLISHED FOR OPPOSITION
08/09/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/20/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/29/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
06/29/2016
ALIE
ASSIGNED TO LIE
06/29/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/29/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
06/29/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/29/2016
DOCK
ASSIGNED TO EXAMINER
06/27/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/22/2016
NWAP
NEW APPLICATION ENTERED
03/21/2016
Continuous trademark protection
Get notified about every new filing that threatens PHARMACEUTICAL SOCIAL ENTERPRISE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.